Peripheral vasospasm during beta-receptor blockade - a comparison between metoprolol and pindolol

Area of Science:

• Cardiology
• Pharmacology
• Vascular Medicine

Background:

• Beta-receptor antagonists are widely used for cardiovascular conditions.
• Vasospastic symptoms, such as Raynaud's phenomenon, can be triggered by certain medications.
• Metoprolol is a commonly prescribed beta-blocker.

Purpose of the Study:

• To investigate the occurrence of vasospastic symptoms in patients treated with metoprolol.
• To determine if switching to a different beta-receptor antagonist, pindolol, alleviates these symptoms.
• To explore the potential class effect of beta-receptor blockade on vasospastic symptoms.

Main Methods:

• Observational study of ten male patients reporting hand vasospasm during metoprolol treatment.
• Assessment for signs of occlusive arterial disease.
• Measurement of temperature reaction to local cooling.
• Evaluation of symptom response after switching to pindolol.

Main Results:

• Ten men experienced vasospastic symptoms in their hands while on metoprolol.
• No evidence of occlusive arterial disease was found in these patients.
• Symptom improvement was not observed after switching from metoprolol to pindolol.
• Local cooling tests did not show improvement post-medication change.

Conclusions:

• Vasospastic symptoms can manifest during beta-receptor blockade therapy, including with metoprolol.
• Predisposed individuals may experience these symptoms regardless of the specific beta-receptor antagonist used.
• Beta-receptor blockade appears to be a potential trigger for vasospasm in susceptible patients.